🇺🇸 FDA
Patent

US 8454965

Method for the treatment of multiple sclerosis

granted A61KA61K2039/505A61K2039/54

Quick answer

US patent 8454965 (Method for the treatment of multiple sclerosis) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon May 30 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Jun 04 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 30 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K2039/505, A61K2039/54, A61K2039/545, A61K31/7052